Publikace UTB
Repozitář publikační činnosti UTB

Effects of reoperation timing on survival among recurrent glioblastoma patients: A retrospective multicentric descriptive study

Repozitář DSpace/Manakin

Zobrazit minimální záznam


dc.title Effects of reoperation timing on survival among recurrent glioblastoma patients: A retrospective multicentric descriptive study en
dc.contributor.author Kalita, Ondřej
dc.contributor.author Kazda, Tomáš
dc.contributor.author Reguli, Štefan
dc.contributor.author Jančálek, Radim
dc.contributor.author Fadrus, Pavel
dc.contributor.author Šlachta, Marek
dc.contributor.author Pospíšil, Petr
dc.contributor.author Krska, Lukas
dc.contributor.author Vrbková, Jana
dc.contributor.author Hrabálek, Lumír
dc.contributor.author Smrčka, Martin
dc.contributor.author Lipina, Radim
dc.relation.ispartof Cancers
dc.identifier.issn 2072-6694 Scopus Sources, Sherpa/RoMEO, JCR
dc.date.issued 2023
utb.relation.volume 15
utb.relation.issue 9
dc.type article
dc.language.iso en
dc.publisher MDPI
dc.identifier.doi 10.3390/cancers15092530
dc.relation.uri https://www.mdpi.com/2072-6694/15/9/2530
dc.subject glioblastoma en
dc.subject reoperation timing en
dc.subject treatment strategy en
dc.description.abstract Glioblastoma inevitably recurs, but no standard regimen has been established for treating this recurrent disease. Several reports claim that reoperative surgery can improve survival, but the effects of reoperation timing on survival have rarely been investigated. We, therefore, evaluated the relationship between reoperation timing and survival in recurrent GBM. A consecutive cohort of unselected patients (real-world data) from three neuro-oncology cancer centers was analyzed (a total of 109 patients). All patients underwent initial maximal safe resection followed by treatment according to the Stupp protocol. Those meeting the following criteria during progression were indicated for reoperation and were further analyzed in this study: (1) The tumor volume increased by >20-30% or a tumor was rediscovered after radiological disappearance; (2) The patient's clinical status was satisfactory (KS = 70% and PS WHO = gr. 2); (3) The tumor was localized without multifocality; (4) The minimum expected tumor volume reduction was above 80%. A univariate Cox regression analysis of postsurgical survival (PSS) revealed a statistically significant effect of reoperation on PSS from a threshold of 16 months after the first surgery. Cox regression models that stratified the Karnofsky score with age adjustment confirmed a statistically significant improvement in PSS for time-to-progression (TTP) thresholds of 22 and 24 months. The patient groups exhibiting the first recurrence at 22 and 24 months had better survival rates than those exhibiting earlier recurrences. For the 22-month group, the HR was 0.5 with a 95% CI of (0.27, 0.96) and a p-value of 0.036. For the 24-month group, the HR was 0.5 with a 95% CI of (0.25, 0.96) and a p-value of 0.039. Patients with the longest survival were also the best candidates for repeated surgery. Later recurrence of glioblastoma was associated with higher survival rates after reoperation. en
utb.faculty Faculty of Humanities
dc.identifier.uri http://hdl.handle.net/10563/1011543
utb.identifier.obdid 43884702
utb.identifier.scopus 2-s2.0-85159559808
utb.identifier.wok 000987086900001
utb.identifier.pubmed 37173996
utb.source j-scopus
dc.date.accessioned 2023-06-12T08:13:23Z
dc.date.available 2023-06-12T08:13:23Z
dc.description.sponsorship 65269705; 00159816; 00209805; Ministerstvo Zdravotnictví Ceské Republiky, MZCR: 00098892, NU20-03-00148, NU21-03-00195
dc.description.sponsorship Ministry of Health of the Czech Republic [NU21-03-00195, NU20-03-00148, 00098892, 00209805, 65269705, 00159816]
dc.rights Attribution 4.0 International
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.rights.access openAccess
utb.contributor.internalauthor Kalita, Ondřej
utb.fulltext.sponsorship This research was funded and supported by the Ministry of Health of the Czech Republic [grants NU21-03-00195, NU20-03-00148 and conceptual development of research organization-FNOL, 00098892; MMCI, 00209805; FNB, 65269705; FNUSA, 00159816; FN Ostrava].
utb.wos.affiliation [Kalita, Ondrej; Slachta, Marek; Hrabalek, Lumir] Palacky Univ Olomouc, Univ Hosp Olomouc, Fac Med & Dent, Dept Neurosurg, Zdravotniku 248 7, Olomouc 77900, Czech Republic; [Kalita, Ondrej] T Bata Univ Zlin, Fac Humanities, Dept Hlth Care Sci, Stefanikova 5670, Zlin 76001, Czech Republic; [Kazda, Tomas; Pospisil, Petr] Masaryk Univ, Masaryk Mem Canc Inst, Fac Med, Dept Radiat Oncol, Zluty Kopec 7, Brno 65653, Czech Republic; [Reguli, Stefan; Krska, Lukas; Lipina, Radim] Univ Ostrava, Univ Hosp Ostrava, Fac Med, Dept Neurosurg, 17 Listopadu 1790 5, Ostrava 70852, Czech Republic; [Jancalek, Radim] Masaryk Univ, St Annes Univ Hosp Brno, Fac Med, Dept Neurosurg, Pekarska 664 53, Brno 60200, Czech Republic; [Fadrus, Pavel; Smrcka, Martin] Masaryk Univ, Univ Hosp Brno, Fac Med, Dept Neurosurg, Jihlavska 20, Brno 62500, Czech Republic; [Vrbkova, Jana] Palacky Univ Olomouc, Inst Mol & Translate Med, Fac Med & Dent, Hnevotinska 133 5, Olomouc 77900, Czech Republic
utb.scopus.affiliation Department of Neurosurgery, Faculty of Medicine and Dentistry, Palacky University in Olomouc, University Hospital Olomouc, Zdravotníků 248/7, Olomouc, 779 00, Czech Republic; Department of Health Care Science, Faculty of Humanities, T. Bata University in Zlin, Stefanikova 5670, Zlín, 760 01, Czech Republic; Department of Radiation Oncology, Faculty of Medicine, Masaryk University, Masaryk Memorial Cancer Institute, Zluty Kopec 7, Brno, 656 53, Czech Republic; Department of Neurosurgery, Faculty of Medicine, University of Ostrava, University Hospital Ostrava, 17. Listopadu 1790/5, Ostrava, 708 52, Czech Republic; Department of Neurosurgery, Faculty of Medicine, Masaryk University, St. Anne’s University Hospital in Brno, Pekarska 664/53, Brno, 602 00, Czech Republic; Department of Neurosurgery, Faculty of Medicine, Masaryk University, University Hospital Brno, Jihlavská 20, Brno, 625 00, Czech Republic; Institute of Molecular and Translate Medicine, Faculty of Medicine and Dentistry, Palacky University in Olomouc, Hnevotinska 133/5, Olomouc, 779 00, Czech Republic
utb.fulltext.projects NU21-03-00195
utb.fulltext.projects NU20-03-00148
utb.fulltext.projects 00098892
utb.fulltext.projects 00209805
utb.fulltext.projects 65269705
utb.fulltext.projects 00159816
Find Full text

Soubory tohoto záznamu

Zobrazit minimální záznam

Attribution 4.0 International Kromě případů, kde je uvedeno jinak, licence tohoto záznamu je Attribution 4.0 International